Clinical Approach to Dyspareunia
Comprehensive Practical Framework1. Symptom Overview
Understanding the clinical significance and classification of dyspareunia
Dyspareunia is one of the most common sexual health complaints in gynecological practice, affecting approximately 10 to 20 percent of women at some point in their lives. Studies suggest that up to 75 percent of women experience painful intercourse at least once, while 10 to 15 percent report persistent or recurrent pain. Despite its prevalence, dyspareunia remains significantly underreported due to patient embarrassment and clinician discomfort with sexual health discussions. The condition profoundly impacts quality of life, intimate relationships, psychological well-being, and reproductive health.
Definition
Dyspareunia is defined as persistent or recurrent genital pain that occurs just before, during, or after sexual intercourse. It is classified as a genito-pelvic pain/penetration disorder in the DSM-5 and represents a complex interplay of physical, psychological, and relational factors. The pain may be superficial (at the vaginal entrance) or deep (with deeper penetration), and this distinction is critical for determining etiology.
Classification by Location of Pain
| Type | Location | Common Causes | Clinical Significance |
|---|---|---|---|
| Superficial (Entry) Dyspareunia | Vulva, vestibule, vaginal introitus | Vulvodynia, vestibulodynia, vaginal atrophy, infections, dermatoses | Pain with initial penetration; often associated with vaginismus |
| Deep Dyspareunia | Deep vagina, cervix, pelvis | Endometriosis, pelvic inflammatory disease, ovarian pathology, adhesions | Pain with deep thrusting; suggests pelvic pathology |
| Combined | Both superficial and deep | Multiple etiologies, central sensitization, chronic pelvic pain syndrome | More complex presentation; often requires multidisciplinary approach |
Classification by Duration and Onset
| Category | Definition | Common Causes | Clinical Significance |
|---|---|---|---|
| Primary (Lifelong) | Pain present since first attempt at intercourse | Congenital anomalies, vestibulodynia, hymenal abnormalities, psychosexual factors | Consider anatomical variants and developmental factors |
| Secondary (Acquired) | Pain develops after a period of pain-free intercourse | Infections, hormonal changes, endometriosis, childbirth trauma, iatrogenic causes | Search for new pathology or triggering event |
Classification by Circumstance
Generalized Dyspareunia
Pain occurs in all situations, with all partners, and with any form of vaginal penetration (including tampon use or gynecological examination). This pattern suggests an organic etiology such as infection, inflammation, or structural abnormality that requires systematic investigation.
Situational Dyspareunia
Pain occurs only in specific circumstances, with certain partners, or in particular positions. This pattern may suggest psychosexual factors, relationship dynamics, or position-dependent anatomical issues such as endometriosis nodules or uterine retroversion.
Classification by Timing
| Timing | Description | Suggests |
|---|---|---|
| Pain with Arousal | Discomfort begins during foreplay or anticipation | Anxiety, prior trauma, vestibulodynia with allodynia |
| Pain at Entry | Sharp or burning pain at initial penetration | Vulvovaginal conditions: vestibulodynia, atrophy, infections, vaginismus |
| Pain During Intercourse | Pain with movement or deep penetration | Endometriosis, pelvic adhesions, ovarian cysts, uterine pathology |
| Pain After Intercourse | Discomfort persists minutes to hours after activity | Pelvic congestion, chronic pelvic pain syndrome, interstitial cystitis |
Key Concept: The Biopsychosocial Model
Dyspareunia is rarely purely physical or purely psychological. The biopsychosocial model recognizes that biological factors (tissue pathology, hormonal status), psychological factors (anxiety, depression, past trauma), and social factors (relationship quality, cultural beliefs) all interact to produce and perpetuate the symptom. Effective management requires addressing all three domains.
Key Epidemiological Facts
- Prevalence: 10 to 20 percent of women report dyspareunia; rates increase to 40 to 50 percent in postmenopausal women not on hormone therapy
- Age distribution: Bimodal peaks in young women (15-24 years) and postmenopausal women
- Underreporting: Only 60 percent of affected women discuss the symptom with healthcare providers
- Impact: Associated with decreased sexual frequency, relationship distress, anxiety, depression, and reduced quality of life
2. Pathophysiology and Mechanisms
Understanding the underlying mechanisms of dyspareunia
Understanding the pathophysiology of dyspareunia requires knowledge of normal genital sensation, the sexual response cycle, and the mechanisms by which various conditions produce pain. The vulva, vagina, and pelvic organs are richly innervated, and pain can arise from peripheral sensitization, central sensitization, or both. The interplay between nociceptive input, psychological processing, and motor responses (such as pelvic floor muscle guarding) creates a complex pain experience.
Neuroanatomy of Genital Sensation
| Structure | Innervation | Function |
|---|---|---|
| Vulva and Vestibule | Pudendal nerve (S2-S4), ilioinguinal nerve, genitofemoral nerve | Highly sensitive to touch, temperature, and pain; dense concentration of free nerve endings |
| Vagina (Lower) | Pudendal nerve branches | Stretch and pressure sensation; pain from inflammation or trauma |
| Vagina (Upper) and Cervix | Pelvic splanchnic nerves (S2-S4), hypogastric plexus | Less sensitive to fine touch; responds to deep pressure and distension |
| Uterus and Adnexa | Hypogastric plexus (T10-L1), pelvic splanchnic nerves | Visceral pain sensation; referred pain to lower back and thighs |
| Pelvic Floor Muscles | Pudendal nerve, levator ani nerve | Proprioception and motor control; hypertonicity causes pain |
Mechanisms of Pain Generation
Peripheral Sensitization
Mechanism: Inflammatory mediators lower the threshold of peripheral nociceptors
Causes: Infection, inflammation, tissue injury, hormonal deficiency
Clinical relevance: Pain is localized and proportional to stimulus; responds to treatment of underlying cause
Central Sensitization
Mechanism: Spinal cord and brain amplify pain signals; allodynia and hyperalgesia develop
Causes: Chronic peripheral input, psychological stress, genetic predisposition
Clinical relevance: Pain persists after tissue healing; widespread tenderness; requires multimodal treatment
Muscular Dysfunction
Mechanism: Pelvic floor hypertonicity creates mechanical obstruction and ischemic pain
Causes: Protective guarding, prior trauma, chronic pain states
Clinical relevance: Vaginismus often coexists; pelvic floor physiotherapy is essential
How Conditions Cause Dyspareunia
| Condition | Mechanism | Treatment Implication |
|---|---|---|
| Vulvovaginal Atrophy (Genitourinary Syndrome of Menopause) | Estrogen deficiency leads to thinning of vaginal epithelium, decreased lubrication, loss of elasticity, and increased pH predisposing to inflammation | Vaginal estrogen restores tissue integrity; lubricants and moisturizers provide symptomatic relief |
| Provoked Vestibulodynia | Peripheral and central sensitization of vestibular nerves; increased nerve fiber density; mast cell activation in vestibular tissue | Multimodal approach: topical therapies, pelvic floor physiotherapy, cognitive behavioral therapy, neuromodulators |
| Endometriosis | Ectopic endometrial implants cause inflammation, fibrosis, and adhesions; deep nodules directly compress during intercourse; creates referred pain patterns | Hormonal suppression reduces inflammation; surgical excision of deep nodules may be required |
| Pelvic Inflammatory Disease | Acute infection causes tissue edema, inflammatory exudate, and cervical motion tenderness; chronic sequelae include adhesions | Antibiotic treatment of acute infection; may require surgical lysis of adhesions |
| Vulvovaginal Candidiasis | Fungal infection triggers inflammatory cascade with tissue edema, erythema, and nerve irritation | Antifungal therapy eliminates infection; recurrent cases may need suppressive therapy |
| Lichen Sclerosus | Chronic inflammatory dermatosis causes epithelial thinning, loss of architecture, introital narrowing, and fissuring | High-potency topical corticosteroids control inflammation; long-term maintenance required |
| Vaginismus | Involuntary contraction of pelvic floor muscles in anticipation of or during penetration; creates mechanical barrier and ischemic pain | Pelvic floor physiotherapy, graduated dilator therapy, cognitive behavioral therapy; address underlying anxiety |
| Interstitial Cystitis/Bladder Pain Syndrome | Bladder inflammation and dysfunction causes referred pain to vagina and pelvis; central sensitization leads to cross-organ sensitization | Multimodal bladder-directed therapy; address pelvic floor dysfunction; neuromodulation |
The Pain-Fear-Avoidance Cycle
Understanding the Vicious Cycle:
- Initial Pain Experience: Physical stimulus causes nociceptive pain
- Fear and Anticipatory Anxiety: Brain associates sexual activity with pain
- Pelvic Floor Guarding: Muscles tense involuntarily in anticipation
- Increased Pain: Muscle tension and reduced lubrication worsen pain
- Avoidance Behavior: Sexual activity is avoided, reinforcing fear
- Central Sensitization: Nervous system becomes increasingly sensitized
- Relationship Strain: Avoidance creates interpersonal conflict, increasing stress
Breaking this cycle requires addressing both the physical cause and the psychological-behavioral components simultaneously.
Hormonal Influences on Vulvovaginal Health
| Hormonal State | Effect on Tissues | Clinical Implications |
|---|---|---|
| Adequate Estrogen | Thick, well-vascularized vaginal epithelium; abundant glycogen; acidic pH; adequate lubrication; elastic tissue | Normal sexual function; resilience to minor trauma |
| Hypoestrogenic State (Menopause, Lactation) | Thin, pale epithelium; reduced vascularity; elevated pH; decreased lubrication; loss of elasticity | Increased susceptibility to trauma, infection, and pain; vaginal estrogen highly effective |
| Combined Hormonal Contraceptives | May reduce vestibular free testosterone; possible vestibular atrophy in susceptible individuals | Consider discontinuation trial in women with vestibulodynia onset after starting contraception |
| Postpartum | Lactation-induced hypoestrogenism; perineal trauma; pelvic floor weakness | Reassurance regarding temporary nature; vaginal estrogen safe during breastfeeding |
Often Overlooked Mechanism: Referred Pain Patterns
Deep dyspareunia may be caused by pathology distant from the vagina. Endometriosis of the uterosacral ligaments causes pain with deep thrusting due to direct compression. Ovarian pathology causes ipsilateral deep pain that may be position-dependent. Interstitial cystitis causes anterior vaginal pain due to bladder-vaginal proximity. Always consider the anatomical relationships when evaluating deep dyspareunia, and remember that multiple conditions may coexist in the same patient.
Complications of Untreated Dyspareunia
Physical Consequences
- Secondary vaginismus development
- Progressive pelvic floor dysfunction
- Central sensitization and chronic pain syndromes
- Delayed diagnosis of underlying pathology
Psychosocial Consequences
- Anxiety and depression
- Sexual aversion and avoidance
- Relationship dysfunction and conflict
- Reduced self-esteem and body image issues
- Infertility due to avoidance of intercourse
3. History Taking
A comprehensive approach to eliciting the dyspareunia history
Red Flags — Require Urgent Evaluation
- Postcoital bleeding — Rule out cervical pathology including malignancy
- Postmenopausal bleeding — Endometrial pathology must be excluded
- Pelvic mass — Ovarian or uterine neoplasm requires imaging
- Fever with pelvic pain — Suggests pelvic inflammatory disease
- Rapid symptom progression — May indicate malignancy or abscess
- Bowel or bladder symptoms with pain — Consider endometriosis or malignancy
- Unintentional weight loss — Malignancy screening indicated
- Signs of domestic violence or coercion — Safety assessment required
Taking a sexual health history requires sensitivity, privacy, and a non-judgmental approach. Begin by normalizing the conversation: “I ask all my patients about sexual health because it’s an important part of overall well-being.” Use open-ended questions initially, then targeted questions based on responses. Ensure the patient is alone (without partner present) for at least part of the history to allow disclosure of sensitive information including relationship concerns or abuse.
Systematic History: The “PAINFUL” Approach
Use the mnemonic “PAINFUL” to ensure comprehensive history taking:
- P — Position and Place: Where exactly is the pain? Is it at the entrance (superficial) or deep inside (deep)? Does position affect it?
- A — Attributes and Associations: What does the pain feel like (burning, sharp, aching)? What other symptoms accompany it (bleeding, discharge, urinary symptoms)?
- I — Inception and Interval: When did this start? Was it always present (primary) or did it develop later (secondary)? Is it constant or intermittent?
- N — Nexus to Cycle: Does the pain vary with menstrual cycle? Is it worse at certain times of the month? Any relationship to ovulation?
- F — Factors (Aggravating and Alleviating): What makes it worse? What helps? Have you tried lubricants, different positions, or any treatments?
- U — Underlying History: Past gynecological history, obstetric history, surgeries, infections, trauma, abuse history, relationship factors
- L — Life Impact: How is this affecting your relationship, mood, quality of life, and desire for intimacy?
Targeted Questions by Suspected Cause
| Suspected Cause | Key Features | Ask This Question |
|---|---|---|
| Vulvovaginal Atrophy | Postmenopausal, vaginal dryness, burning | “Do you notice vaginal dryness even when aroused? Do you have burning or irritation outside of intercourse?” |
| Provoked Vestibulodynia | Entry pain, burning quality, tampon use painful | “Is inserting a tampon painful? Does the pain feel like burning at the vaginal opening? Is the pain triggered by touch?” |
| Endometriosis | Deep pain, cyclical worsening, dysmenorrhea | “Is the pain deep inside rather than at the entrance? Does it worsen around your period? Do you have painful periods?” |
| Vaginismus | Penetration impossible, anticipatory fear | “Do you feel your muscles tighten when penetration is attempted? Does the fear of pain make you tense up beforehand?” |
| Vulvovaginal Candidiasis | Itching, discharge, recurrent episodes | “Do you have itching or a thick white discharge? Have you had yeast infections before? Do symptoms come and go?” |
| Lichen Sclerosus | Itching, skin changes, progressive narrowing | “Have you noticed any skin changes or white patches? Is there itching that keeps you awake? Has the opening become narrower over time?” |
| Pelvic Inflammatory Disease | Bilateral deep pain, discharge, fever history | “Have you had any unusual discharge or fever? Have you been diagnosed with a sexually transmitted infection? Is there pain on both sides?” |
| Interstitial Cystitis/Bladder Pain Syndrome | Urinary frequency, bladder pressure, pain relief with voiding | “Do you urinate more frequently than you feel is normal? Do you feel pressure or pain in your bladder? Does the pain improve after urinating?” |
| Psychosexual Factors | Situational pain, relationship issues, trauma history | “Does the pain occur with all partners and situations, or only sometimes? Have you experienced any trauma or negative sexual experiences? How is your relationship otherwise?” |
Essential Obstetric and Gynecological History
Obstetric History
- Deliveries: Vaginal versus cesarean, episiotomy, perineal tears (degree), instrumental delivery
- Postpartum: When did intercourse resume? Any breastfeeding (causes hypoestrogenism)?
- Complications: Wound infections, poor healing, granulation tissue
- Timing: Did symptoms start after a particular delivery?
Gynecological History
- Menstrual history: Dysmenorrhea, menorrhagia, cycle regularity
- Infections: History of sexually transmitted infections, recurrent candidiasis, bacterial vaginosis
- Surgery: Hysterectomy, oophorectomy, endometriosis surgery, vulvar procedures
- Contraception: Current and past methods, timing of symptom onset relative to contraceptive use
- Menopausal status: Perimenopausal symptoms, use of hormone therapy
Medication and Substance History
Medications That May Cause or Worsen Dyspareunia
- Combined hormonal contraceptives — May cause vestibular atrophy in susceptible individuals
- Selective serotonin reuptake inhibitors (SSRIs) — Decrease arousal and lubrication
- Antihistamines — Systemic drying effect including vaginal mucosa
- Aromatase inhibitors — Profound estrogen depletion
- Tamoxifen — Vaginal dryness and atrophy
- Gonadotropin-releasing hormone agonists — Induce hypoestrogenic state
- Medroxyprogesterone acetate (injectable) — May cause vaginal atrophy
- Anticholinergics — Reduce vaginal secretions
Psychosocial History
- Relationship status: Quality, communication, partner’s response to the problem
- Sexual history: Age at first intercourse, number of partners, sexual orientation
- Trauma history: Sexual abuse, assault, negative sexual experiences (ask sensitively)
- Mental health: Anxiety, depression, body image concerns
- Cultural and religious factors: Beliefs about sexuality, guilt, shame
- Substance use: Alcohol may initially reduce inhibition but impairs arousal; cannabis effects variable
Screening for Intimate Partner Violence and Sexual Trauma
Dyspareunia may be a presenting symptom of intimate partner violence or past sexual trauma. Screen all patients, ensuring privacy (partner not present). Use validated screening questions:
- “Have you ever been in a relationship where you felt unsafe?”
- “Has anyone ever forced you to have sexual contact against your will?”
- “Does your partner support you seeking help for this problem?”
If disclosure occurs, respond with empathy, provide resources, assess safety, and document carefully. Do not pressure disclosure but create a safe space for it.
Practical Tips for Taking a Sensitive History
- Normalize: “Many women experience this — you’re not alone, and it’s treatable”
- Use patient’s language: Reflect back the terms they use for anatomy and activities
- Be specific: Vague questions yield vague answers; ask exactly what hurts and when
- Assess the relationship: Partner’s response to dyspareunia (supportive versus pressuring) affects outcomes
- Ask about desire: Distinguish between pain causing avoidance versus low desire causing dyspareunia (inadequate arousal)
- Validate: Acknowledge how distressing this symptom is before moving to examination
4. Physical Examination
A systematic approach to the gynecological examination for dyspareunia
Examination Framework: The examination for dyspareunia follows a structured “Outside-to-Inside” approach, beginning with external inspection and progressing to internal examination only after adequate assessment of the vulva and vestibule. The goal is to reproduce the patient’s pain to identify its source while minimizing distress.
Preparation and Consent
- Explain the purpose: “I need to examine you to find the cause of your pain. I’ll be gentle and you can stop me at any time.”
- Offer control: Provide a mirror so the patient can see what you’re doing; this reduces anxiety and aids education
- Chaperone: Offer a chaperone regardless of examiner gender; document if declined
- Positioning: Lithotomy position with adequate draping; ensure warmth and privacy
- Trauma-informed approach: For patients with trauma history, consider whether examination is essential today; proceed slowly with explicit consent at each step
General Inspection
- Body habitus: Signs of hypoestrogenism (low body weight, athletic habitus), hyperandrogenism (hirsutism, acne)
- Affect: Anxiety level, pain behaviors, signs of depression
- Mobility: Ability to position for examination (musculoskeletal issues may contribute to dyspareunia)
- Skin: Generalized dermatological conditions that may affect vulva (eczema, psoriasis, lichen planus)
External Genital Examination
Vulvar Inspection
| Structure | Normal Findings | Abnormal Findings and Significance |
|---|---|---|
| Mons Pubis and Labia Majora | Hair-bearing, normal skin texture, symmetric | Lesions, ulcers, masses, asymmetry (cysts, abscesses, neoplasms) |
| Labia Minora | Pink, moist, variable size and shape | White patches (lichen sclerosus), erythema (dermatitis, candidiasis), fusion (lichen sclerosus), hypertrophy (may cause mechanical irritation) |
| Clitoris and Prepuce | Visible, mobile prepuce | Buried clitoris, adhesions, phimosis (lichen sclerosus progression) |
| Vestibule | Pink, smooth mucosa between Hart’s line and hymen | Erythema (vestibulodynia, infection), pallor (atrophy), papillae (normal variant versus condyloma) |
| Urethral Meatus | Midline, slit-like or stellate | Caruncle (prolapsed urethral mucosa), discharge, tenderness (urethritis) |
| Hymen | Variable configuration; may have remnants (carunculae) | Imperforate or microperforate hymen (primary dyspareunia), rigid hymenal remnants, septal bands |
| Perineum | Intact skin between vagina and anus | Scarring (obstetric trauma, episiotomy), fissures (lichen sclerosus), fistulae |
| Perianal Area | Normal skin, no lesions | Fissures, hemorrhoids, white patches (lichen sclerosus often involves perianal area in “figure-of-eight” pattern) |
Cotton Swab (Q-tip) Test for Vestibulodynia
Technique
Using a moistened cotton swab, gently touch the vestibule at multiple points (typically 12 o’clock, 2, 4, 6, 8, and 10 o’clock positions) and ask the patient to rate pain on a 0-10 scale at each location. Begin with a non-vestibular site (inner thigh) to establish baseline.
Positive test: Localized tenderness and pain reproduction, particularly at the posterior vestibule (4-8 o’clock), with pain disproportionate to the light touch stimulus (allodynia). This is highly suggestive of provoked vestibulodynia.
Document: Map the areas of tenderness and pain scores for comparison at follow-up.
Pelvic Floor Muscle Assessment
Before internal examination with a speculum, assess the pelvic floor with a single lubricated finger:
| Assessment | Technique | Findings and Significance |
|---|---|---|
| Muscle Tone at Rest | Insert finger 2-3 cm, assess baseline tension of levator ani | Elevated tone (hypertonicity) — suggests vaginismus or chronic guarding; may limit further examination |
| Tenderness | Palpate levator ani at 4-5 o’clock and 7-8 o’clock positions | Tenderness or trigger points — pelvic floor myalgia, often accompanies other causes |
| Voluntary Contraction | Ask patient to “squeeze around my finger” | Absent or weak contraction — pelvic floor weakness; excessive contraction — overactivity |
| Voluntary Relaxation | Ask patient to “let go” or “bear down gently” | Inability to relax — non-relaxing pelvic floor; paradoxical contraction — dyssynergia |
| Pain Reproduction | Ask “Is this similar to your pain during intercourse?” | Positive — confirms pelvic floor involvement; helps patient understand the source |
Speculum Examination
- Size selection: Use the smallest speculum that provides adequate visualization; consider pediatric speculum for significant atrophy or hypertonicity
- Lubrication: Use water or small amount of water-based lubricant (excessive lubricant may interfere with microscopy)
- Insertion: Insert slowly, angled posteriorly, with patient’s voluntary relaxation; stop if there is significant pain
- If examination impossible: Do not force; document “examination not possible due to pain/hypertonicity” and consider examination under anesthesia or after pelvic floor therapy if indicated
Vaginal Assessment
| Finding | Description | Conditions |
|---|---|---|
| Vaginal Epithelium | Color, rugae, moisture, friability | Pale, smooth, dry, friable — vaginal atrophy; erythema — infection, inflammation |
| Discharge | Color, consistency, odor | Thick white — candidiasis; gray-white with odor — bacterial vaginosis; purulent — trichomoniasis, cervicitis |
| Lesions | Ulcers, masses, polyps | Vaginal ulcers — herpes, trauma, erosive lichen planus; masses — cysts, neoplasms |
| Scarring or Stenosis | Narrowing, bands, loss of elasticity | Post-surgical, post-radiation, lichen sclerosus, lichen planus |
| Cervix | Position, appearance, discharge | Cervicitis (erythema, discharge), ectropion, nabothian cysts (normal variant), lesions (require further evaluation) |
Bimanual Examination
The bimanual examination is essential for evaluating deep dyspareunia:
| Structure | Technique | Findings and Significance |
|---|---|---|
| Cervical Motion | Gently move cervix side to side | Cervical motion tenderness — pelvic inflammatory disease, endometriosis, ectopic pregnancy |
| Uterus | Palpate size, position, mobility, tenderness | Enlarged — fibroids, adenomyosis; fixed — adhesions, endometriosis; retroverted — may predispose to deep dyspareunia with certain positions |
| Adnexa | Palpate each adnexal area | Mass — ovarian cyst, neoplasm, endometrioma; tenderness — infection, torsion, endometriosis |
| Uterosacral Ligaments | Palpate posterior cul-de-sac and uterosacral ligaments | Nodularity, tenderness — highly suggestive of deep infiltrating endometriosis |
| Anterior Vaginal Wall | Palpate bladder base and urethra | Tenderness — interstitial cystitis/bladder pain syndrome, urethral syndrome |
| Rectovaginal Septum | Rectovaginal examination if deep endometriosis suspected | Nodularity — rectovaginal endometriosis; tenderness — confirms deep infiltrating disease |
Expected Examination Findings by Etiology
| Condition | External Findings | Internal Findings | Pelvic Floor |
|---|---|---|---|
| Vulvovaginal Atrophy | Pale, thin labia; loss of subcutaneous fat; urethral prominence | Pale, dry, smooth vagina; loss of rugae; friability | Often normal; may have secondary hypertonicity |
| Provoked Vestibulodynia | Erythema of vestibule (variable); positive Q-tip test | Usually normal | Often hypertonic; tenderness of levator ani |
| Lichen Sclerosus | White, crinkled skin; loss of architecture; introital narrowing; fissures | Usually normal (does not involve vagina) | May have secondary hypertonicity |
| Vulvovaginal Candidiasis | Erythema, edema, satellite lesions, fissures | Thick white discharge; erythematous vaginal walls | Usually normal |
| Endometriosis | Usually normal | Uterosacral nodularity; fixed, retroverted uterus; adnexal mass | May have secondary hypertonicity |
| Vaginismus | Usually normal appearance | Examination may not be possible | Severe hypertonicity; involuntary contraction with attempted penetration |
| Pelvic Inflammatory Disease | May have discharge at introitus | Cervical discharge; cervical motion tenderness; adnexal tenderness | Tenderness but not usually hypertonicity |
Important Teaching Point
A normal examination does not exclude significant pathology. Provoked vestibulodynia may show only subtle erythema or appear entirely normal. Endometriosis is frequently not palpable, especially in earlier stages. Interstitial cystitis/bladder pain syndrome typically has a normal gynecological examination. Psychological contributions cannot be “seen” on examination. The history remains the most important diagnostic tool, and a negative examination should prompt consideration of further investigation or empiric treatment rather than dismissal of the patient’s symptoms.
Documentation Tips
- Draw a vulvar map marking areas of tenderness and lesions
- Record Q-tip test results with pain scores at each location
- Document pelvic floor tone (normal, increased, decreased) and tenderness
- Note whether the examination reproduced the patient’s pain
- Record if examination was limited and why (pain, hypertonicity, patient request)
- Include patient’s emotional response to examination for future reference
5. Differential Diagnosis
Systematic approach organized by location, probability, and clinical features
The differential diagnosis of dyspareunia is best approached by first determining the location of pain (superficial versus deep) and then considering causes by probability. Remember that multiple conditions frequently coexist, and pelvic floor dysfunction often develops secondary to any chronic pain source.
Superficial (Entry) Dyspareunia
Step-by-Step Approach to Superficial Dyspareunia:
- Step 1: Rule out infection — Perform vulvovaginal swabs and treat if positive
- Step 2: Assess for atrophy — Evaluate estrogen status and examine for signs of hypoestrogenism
- Step 3: Examine for dermatoses — Look carefully for lichen sclerosus, lichen planus, dermatitis
- Step 4: Perform Q-tip test — Localize vestibular tenderness suggesting vestibulodynia
- Step 5: Assess pelvic floor — Evaluate for hypertonicity and vaginismus
| Probability | Condition | Key Features | Red Flags |
|---|---|---|---|
| COMMON (approximately 60-70%) | Provoked Vestibulodynia | Burning at entry, positive Q-tip test, may have erythema at vestibule | None specific; diagnosis of exclusion |
| COMMON | Vulvovaginal Atrophy (Genitourinary Syndrome of Menopause) | Postmenopausal or hypoestrogenic state, vaginal dryness, thin pale mucosa | Postmenopausal bleeding requires endometrial evaluation |
| COMMON | Vulvovaginal Candidiasis | Itching, thick white discharge, erythema, recurrent episodes | Recurrent (4+ per year) requires investigation for diabetes, immunosuppression |
| COMMON | Pelvic Floor Hypertonicity/Vaginismus | Inability to tolerate penetration, anticipatory tightening, levator tenderness | Complete inability to examine may indicate severe vaginismus or trauma |
| LESS COMMON (approximately 20-30%) | Lichen Sclerosus | White patches, architectural changes, itching, fissures, introital narrowing | Non-healing ulcer or mass — rule out squamous cell carcinoma |
| LESS COMMON | Lichen Planus (Erosive) | Painful erosions, glazed erythema, vaginal involvement, lacy white striae | Progressive vaginal stenosis; oral lesions may coexist |
| LESS COMMON | Vulvar Dermatitis (Contact or Irritant) | Itching, burning, erythema, history of irritant exposure or allergen | Failure to respond to elimination of irritants |
| LESS COMMON | Genital Herpes Simplex | Recurrent painful ulcers, prodromal tingling, history of outbreaks | Primary outbreak more severe; consider immunosuppression if frequent recurrence |
| LESS COMMON | Bartholin Gland Cyst or Abscess | Unilateral labial swelling at 5 or 7 o’clock position, may be fluctuant | Abscess with fever requires drainage; recurrent cysts in older women need biopsy |
| UNCOMMON BUT IMPORTANT (approximately 5-10%) | Vulvar Intraepithelial Neoplasia or Vulvar Cancer | Raised lesion, ulcer, pigmented lesion, pruritus not responding to treatment | Any suspicious lesion requires biopsy |
| UNCOMMON | Hymenal Abnormalities | Primary dyspareunia, rigid hymenal bands, microperforate or septate hymen | Consider if symptoms since first intercourse attempt |
| UNCOMMON | Vulvar Varicosities | Visible dilated veins, heaviness, worsens with standing, may worsen in pregnancy | Usually benign but may indicate pelvic congestion syndrome |
Deep Dyspareunia
Step-by-Step Approach to Deep Dyspareunia:
- Step 1: Rule out infection — Consider pelvic inflammatory disease, especially with fever or discharge
- Step 2: Assess for endometriosis — Inquire about dysmenorrhea, cyclical pain, infertility; examine for nodularity
- Step 3: Evaluate adnexa — Palpate for ovarian masses or tenderness
- Step 4: Consider bladder involvement — Ask about urinary symptoms suggesting interstitial cystitis
- Step 5: Assess uterine position — Retroverted uterus may cause positional deep pain
| Probability | Condition | Key Features | Red Flags |
|---|---|---|---|
| COMMON (approximately 50-60%) | Endometriosis | Cyclical worsening, dysmenorrhea, dyschezia, infertility, uterosacral nodularity | Bowel or bladder symptoms suggest deep infiltrating disease |
| COMMON | Pelvic Inflammatory Disease (Acute or Chronic Sequelae) | Bilateral pain, discharge, fever (acute); adhesions and chronic pain (chronic) | Fever, peritoneal signs require urgent treatment |
| COMMON | Ovarian Cysts | Unilateral deep pain, may be positional, palpable adnexal mass | Acute severe pain — consider torsion or rupture; postmenopausal cyst needs evaluation |
| LESS COMMON (approximately 20-30%) | Interstitial Cystitis/Bladder Pain Syndrome | Urinary frequency, urgency, suprapubic pain, pain relief with voiding | Hematuria requires cystoscopy to rule out malignancy |
| LESS COMMON | Adenomyosis | Heavy menstrual bleeding, dysmenorrhea, uniformly enlarged tender uterus | Irregular bleeding needs endometrial evaluation |
| LESS COMMON | Uterine Fibroids | Enlarged irregular uterus, heavy bleeding, bulk symptoms | Rapid growth, postmenopausal growth — consider leiomyosarcoma |
| LESS COMMON | Retroverted Uterus | Deep pain worse in certain positions, uterus tilted posteriorly on examination | Fixed retroversion suggests adhesions or endometriosis |
| LESS COMMON | Pelvic Congestion Syndrome | Chronic dull aching, worse with prolonged standing, vulvar varicosities | Acute worsening — consider thrombosis |
| UNCOMMON BUT SERIOUS (approximately 5-10%) | Pelvic Adhesions (Post-surgical or Post-infectious) | History of surgery or infection, pulling sensation, positional pain | Bowel symptoms suggest bowel involvement |
| UNCOMMON | Ovarian or Pelvic Malignancy | Weight loss, bloating, early satiety, new onset pain in older women | Any suspicious symptoms in postmenopausal women require urgent evaluation |
| UNCOMMON | Irritable Bowel Syndrome | Altered bowel habits, bloating, abdominal pain relieved by defecation | Rectal bleeding, weight loss, family history of colorectal cancer |
Anatomical Approach to Dyspareunia
Vulva and Vestibule
Provoked vestibulodynia
Lichen sclerosus
Lichen planus
Vulvar dermatitis
Vulvovaginal candidiasis
Genital herpes simplex
Bartholin gland pathology
Vagina and Cervix
Vulvovaginal atrophy
Vaginitis (infectious)
Vaginal stenosis
Cervicitis
Cervical pathology
Post-surgical scarring
Vaginal mesh complications
Uterus and Adnexa
Endometriosis
Adenomyosis
Uterine fibroids
Ovarian cysts
Pelvic inflammatory disease
Pelvic adhesions
Ovarian neoplasms
Adjacent Structures and Functional
Interstitial cystitis/bladder pain syndrome
Pelvic floor hypertonicity
Pelvic congestion syndrome
Irritable bowel syndrome
Pudendal neuralgia
Musculoskeletal (hip, spine)
Psychosexual factors
Drug-Induced and Iatrogenic Dyspareunia
| Drug or Intervention | Mechanism | Characteristics | Management |
|---|---|---|---|
| Combined Hormonal Contraceptives | Suppression of ovarian androgens; possible vestibular atrophy | Entry dyspareunia developing after starting contraception; vestibular tenderness | Trial of discontinuation (3-6 months); consider non-hormonal alternatives |
| Selective Serotonin Reuptake Inhibitors (SSRIs) | Decreased libido and arousal leading to inadequate lubrication | Reduced desire, delayed orgasm, vaginal dryness | Dose reduction, switch to bupropion or mirtazapine; add lubricant |
| Antihistamines | Anticholinergic effect reduces vaginal secretions | Vaginal dryness with systemic antihistamine use | Use non-sedating antihistamines; add vaginal lubricant |
| Aromatase Inhibitors | Profound estrogen depletion | Severe vaginal atrophy, more pronounced than natural menopause | Vaginal estrogen (discuss with oncologist); ospemifene; lubricants |
| Tamoxifen | Mixed estrogen agonist/antagonist; vaginal atrophy in some women | Variable — some women have estrogenic effects, others have atrophy | Vaginal moisturizers and lubricants; low-dose vaginal estrogen if needed |
| Gonadotropin-Releasing Hormone Agonists | Induce medical menopause | Rapid onset of hypoestrogenic symptoms including dyspareunia | Add-back hormone therapy; vaginal estrogen |
| Depot Medroxyprogesterone Acetate | Suppression of ovarian function; hypoestrogenic state | Vaginal dryness, decreased libido | Vaginal estrogen is safe to use concurrently; consider alternative contraception |
| Post-Surgical (Episiotomy, Perineal Repair) | Scar tissue, nerve damage, altered anatomy | Localized tenderness at scar, tight band, superficial dyspareunia | Scar massage, pelvic floor physiotherapy; surgical revision if severe |
| Pelvic Radiation Therapy | Fibrosis, vaginal stenosis, mucosal damage | Progressive vaginal narrowing and dryness; may develop years post-treatment | Vaginal dilators, estrogen therapy, lubricants; hyperbaric oxygen in severe cases |
| Vaginal Mesh for Prolapse | Mesh exposure, contraction, partner dyspareunia from mesh | New onset dyspareunia after mesh placement; partner reports scratching sensation | Examination for mesh exposure; surgical excision if symptomatic |
Quick Reference: “If You See This, Think This”
| Clinical Clue | Think This First | Next Step |
|---|---|---|
| Burning at entry with positive Q-tip test | Provoked vestibulodynia | Pelvic floor assessment; multimodal treatment plan |
| Postmenopausal with vaginal dryness | Genitourinary syndrome of menopause | Vaginal estrogen therapy |
| White patches with architectural distortion | Lichen sclerosus | High-potency topical corticosteroid; biopsy if uncertain |
| Cyclical deep pain with dysmenorrhea | Endometriosis | Pelvic ultrasound; consider laparoscopy; hormonal suppression |
| Itching with thick white discharge | Vulvovaginal candidiasis | Confirm with microscopy or culture; antifungal treatment |
| Unable to tolerate examination due to muscle guarding | Vaginismus | Pelvic floor physiotherapy; graduated dilator therapy |
| Urinary frequency with suprapubic pain | Interstitial cystitis/bladder pain syndrome | Urology referral; bladder diary; potassium sensitivity test |
| Deep pain worse in certain positions | Retroverted uterus or positional pathology | Position modification; evaluate for endometriosis if fixed retroversion |
| Pain onset after starting oral contraceptive | Hormonally-mediated vestibulodynia | Trial of contraceptive discontinuation (3-6 months) |
| Unilateral swelling at 5 or 7 o’clock | Bartholin gland cyst or abscess | Incision and drainage if abscess; marsupialization for recurrence |
Remember: Multiple Diagnoses Are the Rule
In chronic dyspareunia, multiple conditions commonly coexist. A woman with endometriosis often develops secondary pelvic floor hypertonicity. Vestibulodynia frequently coexists with vaginismus. Vulvovaginal atrophy may be complicated by recurrent candidiasis. Always assess for secondary pelvic floor dysfunction regardless of the primary diagnosis, and address all contributing factors for successful treatment.
6. Diagnostic Investigations
A stepwise, cost-effective approach guided by clinical suspicion
The diagnosis of dyspareunia is primarily clinical, based on history and physical examination. Investigations serve to confirm suspected diagnoses, exclude serious pathology, and guide treatment. A stepwise approach prevents unnecessary testing while ensuring important conditions are not missed.
Baseline Investigations for Most Patients
| Investigation | Purpose | What to Look For | Practical Points |
|---|---|---|---|
| Vaginal pH Testing | Assess estrogen status and infection | pH greater than 4.5 suggests atrophy or bacterial vaginosis; pH less than 4.5 is normal or candidiasis | Simple bedside test; use pH paper on vaginal sidewall (avoid cervical mucus) |
| Vaginal Wet Mount Microscopy | Identify infection | Yeast and pseudohyphae (candidiasis); clue cells (bacterial vaginosis); trichomonads; parabasal cells (atrophy) | Immediate examination improves sensitivity; saline and potassium hydroxide preparations |
| Vaginal and Endocervical Swabs | Screen for sexually transmitted infections | Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis | Nucleic acid amplification testing is gold standard; self-collected swabs acceptable |
| Vulvar and Vaginal Culture | Identify causative organism in suspected infection | Candida species identification (especially if recurrent or treatment-resistant) | Request speciation; non-albicans species may require different treatment |
When to Investigate Further
Not all patients with dyspareunia require extensive investigation. Consider further testing when:
- Deep dyspareunia is present (suggests pelvic pathology)
- Abnormal findings on bimanual examination (mass, nodularity, tenderness)
- Red flag symptoms are present (bleeding, weight loss, rapid progression)
- Symptoms do not respond to initial empiric treatment
- Diagnosis remains uncertain after clinical assessment
Targeted Investigations by Suspected Etiology
If Suspecting Vulvovaginal Atrophy (Genitourinary Syndrome of Menopause)
First-Line Tests
- Clinical diagnosis: Usually sufficient based on history and examination
- Vaginal pH: Greater than 5.0 supports diagnosis
- Vaginal maturation index: Increased parabasal cells on cytology indicates hypoestrogenism
Second-Line Tests (If Diagnosis Uncertain)
- Serum estradiol and FSH: Confirms menopausal status if unclear
- Vulvar biopsy: If skin changes suggest alternative diagnosis (lichen sclerosus, malignancy)
If Suspecting Provoked Vestibulodynia
Diagnostic Approach
- Clinical diagnosis: Based on positive Q-tip test with pain localized to vestibule
- No specific diagnostic test exists — diagnosis of exclusion
- Rule out infection: Vaginal swabs to exclude candidiasis, herpes
Consider If Atypical Features
- Vulvar biopsy: Only if visible lesion or diagnostic uncertainty; not routinely indicated
- Hormonal panel: If onset associated with hormonal contraceptive (testosterone, sex hormone-binding globulin)
If Suspecting Endometriosis
First-Line Tests
- Transvaginal ultrasound: Can identify endometriomas (sensitivity approximately 90%); limited for peritoneal disease
- CA-125: May be elevated but lacks sensitivity and specificity; not recommended for diagnosis
Second-Line Tests
- Pelvic MRI: Superior for deep infiltrating endometriosis; evaluate rectovaginal septum, uterosacral ligaments, bladder
- Diagnostic laparoscopy: Gold standard for definitive diagnosis; allows simultaneous treatment
If Suspecting Lichen Sclerosus or Other Dermatoses
First-Line Tests
- Clinical diagnosis: Classic appearance may be diagnostic
- Vulvar biopsy: Recommended to confirm diagnosis, especially before long-term steroid treatment
Biopsy Indications
- Diagnostic uncertainty
- Failure to respond to treatment
- Suspicious lesion (raised, ulcerated, hyperpigmented) — rule out malignancy
- Before initiating long-term potent topical steroids
If Suspecting Pelvic Inflammatory Disease
First-Line Tests
- Endocervical swabs: Nucleic acid amplification testing for Chlamydia and Gonorrhea
- Vaginal wet mount: Assess for bacterial vaginosis, trichomonas
- Complete blood count: Leukocytosis supports but does not confirm diagnosis
- C-reactive protein or erythrocyte sedimentation rate: Elevated inflammatory markers
Second-Line Tests
- Transvaginal ultrasound: May show tubo-ovarian abscess, hydrosalpinx, free fluid
- Endometrial biopsy: Histologic evidence of endometritis confirms upper genital tract infection
- Laparoscopy: Definitive but rarely needed; reserved for diagnostic uncertainty or treatment failure
If Suspecting Interstitial Cystitis/Bladder Pain Syndrome
First-Line Tests
- Urinalysis and urine culture: Exclude urinary tract infection
- Bladder diary: Document frequency, urgency, volumes; supports diagnosis
- Post-void residual: Exclude retention
Second-Line Tests (Urology Referral)
- Cystoscopy with hydrodistension: May show glomerulations or Hunner lesions; also therapeutic
- Potassium sensitivity test: Positive test supports diagnosis but not routinely used
- Urodynamic studies: If voiding dysfunction suspected
Imaging in Dyspareunia
| Imaging Modality | Indications | What It Can Detect | Limitations |
|---|---|---|---|
| Transvaginal Ultrasound | First-line for deep dyspareunia; adnexal mass; abnormal bleeding | Ovarian cysts, endometriomas, fibroids, adenomyosis, hydrosalpinx | Operator-dependent; limited for peritoneal endometriosis and adhesions |
| Pelvic MRI | Suspected deep infiltrating endometriosis; characterization of complex mass | Rectovaginal endometriosis, bladder endometriosis, adenomyosis, uterosacral nodules | Expensive; requires expertise in interpretation; not first-line |
| Pelvic Venography or MR Venography | Suspected pelvic congestion syndrome | Dilated pelvic veins, ovarian vein reflux | Specialized test; venography is invasive |
| Transabdominal Ultrasound | Cannot tolerate transvaginal probe; virgin; severe vaginismus | Large masses, hydronephrosis, full bladder assessment | Lower resolution for pelvic organs than transvaginal approach |
Empiric Treatment Trials as Diagnostic Tools
Therapeutic Trial Approach
When the diagnosis is probable but not certain, a therapeutic trial can serve as both treatment and diagnostic confirmation. Response to empiric therapy supports the suspected diagnosis.
- Suspected vulvovaginal atrophy: Vaginal estrogen for 4-8 weeks — improvement confirms diagnosis
- Suspected vulvovaginal candidiasis: Antifungal treatment — resolution confirms diagnosis (obtain culture if recurrent)
- Suspected endometriosis: Combined oral contraceptive or progestin for 3 months — symptom improvement supports diagnosis
- Suspected pelvic inflammatory disease: Empiric antibiotics per guidelines — clinical response expected within 72 hours
- Suspected hormonally-mediated vestibulodynia: Discontinuation of hormonal contraceptive for 3-6 months — improvement supports causal relationship
When Is Vulvar Biopsy Indicated?
| Indication | Rationale | Technique |
|---|---|---|
| Visible lesion with uncertain diagnosis | Distinguish between dermatoses; exclude malignancy | Punch biopsy (3-4 mm) from representative area |
| Suspected lichen sclerosus or lichen planus | Confirm diagnosis before long-term steroid therapy | Biopsy from active edge of lesion, not eroded center |
| Failure to respond to appropriate treatment | Reconsider diagnosis; rule out malignancy | Biopsy most abnormal-appearing area |
| Raised, ulcerated, or pigmented lesion | Exclude vulvar intraepithelial neoplasia or carcinoma | Include lesion margin in biopsy |
| Change in appearance of known dermatosis | Lichen sclerosus has 4-5% malignancy risk; monitor for change | Biopsy any new or changing lesion |
Practical Investigation Tips
- Start simple: Most superficial dyspareunia can be diagnosed clinically with vaginal pH, wet mount, and Q-tip test
- Reserve imaging for deep dyspareunia: Transvaginal ultrasound is the appropriate first-line imaging study
- Biopsy visible lesions: Do not assume a diagnosis without histological confirmation if there is any uncertainty
- Screen for sexually transmitted infections: Even in long-term monogamous relationships (patient may not know partner status)
- Refer appropriately: Urology for bladder symptoms, dermatology for complex skin disease, colorectal surgery for bowel endometriosis
- Do not over-investigate: Provoked vestibulodynia and vaginismus are clinical diagnoses; excessive testing delays treatment
7. Pattern Recognition and Clinical Decision-Making
Practical algorithms and decision pathways
Step 1: Is This Urgent?
| Clinical Scenario | Urgency Level | Immediate Action |
|---|---|---|
| Fever with pelvic pain and cervical motion tenderness | EMERGENT | Suspect pelvic inflammatory disease; initiate antibiotics immediately; consider admission if toxic |
| Acute severe unilateral pelvic pain with adnexal mass | EMERGENT | Rule out ovarian torsion or ruptured cyst; urgent ultrasound; surgical consultation |
| Postmenopausal bleeding with dyspareunia | URGENT | Endometrial evaluation required (ultrasound and/or biopsy); refer within 2 weeks |
| Suspicious vulvar lesion (raised, ulcerated, non-healing) | URGENT | Vulvar biopsy to exclude malignancy; refer within 2 weeks |
| Signs of domestic violence or sexual assault | URGENT | Safety assessment; offer resources; forensic examination if recent assault; document carefully |
| Chronic dyspareunia without red flags | ROUTINE | Systematic evaluation; schedule adequate time for history and examination |
| Postpartum dyspareunia (common, expected) | ROUTINE | Reassurance; assess for perineal scarring; consider vaginal estrogen if breastfeeding |
Step 2: Classify by Location of Pain
Superficial (Entry) Dyspareunia
Pain at the vaginal entrance or with initial penetration
Proceed to Algorithm A
Deep Dyspareunia
Pain with deep penetration or thrusting
Proceed to Algorithm B
Step 3: Follow the Appropriate Algorithm
Algorithm A: Superficial (Entry) Dyspareunia
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Postmenopausal or breastfeeding; vaginal dryness; pale, thin mucosa | Genitourinary syndrome of menopause (vulvovaginal atrophy) | Start vaginal estrogen; recommend lubricants; reassess in 4-8 weeks |
| Burning at entry; positive Q-tip test at vestibule; normal appearance or mild erythema | Provoked vestibulodynia | Pelvic floor physiotherapy referral; topical lidocaine; consider multimodal therapy |
| Itching; thick white discharge; erythema; history of recurrence | Vulvovaginal candidiasis | Confirm with microscopy/culture; treat with antifungal; investigate if recurrent |
| White patches; loss of labial architecture; fissures; “figure-of-eight” distribution | Lichen sclerosus | Biopsy to confirm; high-potency topical corticosteroid; long-term surveillance |
| Unable to tolerate penetration; severe anticipatory anxiety; pelvic floor guarding | Vaginismus | Pelvic floor physiotherapy; graduated dilator therapy; address psychological factors |
| Onset after starting combined hormonal contraceptive; young woman; vestibular tenderness | Hormonally-associated vestibulodynia | Discontinue hormonal contraception for 3-6 months; switch to non-hormonal method |
| Recurrent painful ulcers; prodromal symptoms; history of outbreaks | Genital herpes simplex | Confirm with swab during outbreak; antiviral treatment; suppressive therapy if frequent |
| Post-delivery; localized scar tenderness; rigid perineum | Perineal scar dyspareunia | Scar massage; pelvic floor physiotherapy; surgical revision if severe and refractory |
Algorithm B: Deep Dyspareunia
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Cyclical worsening; dysmenorrhea; uterosacral nodularity; dyschezia around menses | Endometriosis | Transvaginal ultrasound; consider MRI; hormonal suppression; refer for laparoscopy if needed |
| Acute onset; bilateral pain; fever; cervical motion tenderness; mucopurulent discharge | Pelvic inflammatory disease | STI testing; empiric antibiotics immediately; close follow-up; contact tracing |
| Unilateral deep pain; palpable adnexal mass; may be position-dependent | Ovarian cyst or mass | Transvaginal ultrasound; assess complexity; refer if suspicious features |
| Urinary frequency; urgency; suprapubic discomfort; pain improves after voiding | Interstitial cystitis/bladder pain syndrome | Urinalysis to exclude infection; bladder diary; urology referral |
| Heavy menstrual bleeding; diffusely enlarged tender uterus; secondary dysmenorrhea | Adenomyosis | Transvaginal ultrasound; MRI if uncertain; hormonal management; consider hysterectomy if severe |
| Pain worse in certain positions; mobile retroverted uterus; otherwise normal examination | Retroverted uterus (positional) | Position modification (avoid deep penetration positions); rule out fixed retroversion |
| Chronic dull aching; worse with standing; vulvar varicosities; multiparous | Pelvic congestion syndrome | Pelvic venography or MR venography; interventional radiology consultation |
| Previous pelvic surgery or infection; pulling sensation; adhesion band palpable | Pelvic adhesions | Trial of physiotherapy; laparoscopic adhesiolysis if severe and refractory |
“What Do I Do If…” Decision Reference
| Clinical Situation | Immediate Action | Next Step |
|---|---|---|
| Patient cannot tolerate any vaginal examination | Do not force; document; defer internal examination | Pelvic floor physiotherapy first; consider examination under anesthesia if pathology suspected |
| Q-tip test is exquisitely positive | Diagnose provoked vestibulodynia; assess pelvic floor | Multimodal approach: pelvic floor physiotherapy, topical lidocaine, consider amitriptyline |
| Empiric treatment for candidiasis has failed | Obtain vulvovaginal culture with speciation | Non-albicans species may require boric acid or different azole; consider other diagnoses |
| Vaginal estrogen has not helped atrophy after 8 weeks | Reassess diagnosis; ensure adequate dose and compliance | Consider other causes; add pelvic floor physiotherapy; try different estrogen formulation |
| Deep dyspareunia persists despite normal ultrasound | Consider endometriosis (peritoneal disease not seen on ultrasound) | MRI pelvis; empiric hormonal treatment; consider diagnostic laparoscopy |
| Partner reports scratching sensation during intercourse | Examine for vaginal mesh exposure | If mesh exposed, refer to urogynecology for possible excision |
| Patient discloses history of sexual trauma | Listen without judgment; validate experience; ensure safety | Trauma-informed care; psychology/counseling referral; proceed slowly with physical treatment |
| Symptoms persist despite addressing identified pathology | Reassess for additional diagnoses; evaluate pelvic floor | Multiple diagnoses common; address secondary pelvic floor dysfunction; consider central sensitization |
| Patient requests referral to specialist | Acknowledge limitations of primary care; facilitate referral | Refer to vulvar clinic, pelvic pain specialist, or sexual medicine clinic |
When to Refer
Vulvar Dermatology or Vulvar Clinic
- Lichen sclerosus not responding to treatment
- Suspected lichen planus (complex management)
- Diagnostic uncertainty regarding vulvar dermatosis
- Vulvar lesion requiring biopsy
Pelvic Floor Physiotherapy
- All patients with pelvic floor hypertonicity
- Vaginismus (essential component of treatment)
- Provoked vestibulodynia (first-line treatment)
- Postpartum perineal scar dyspareunia
Gynecology or Pelvic Pain Specialist
- Suspected endometriosis requiring laparoscopy
- Complex pelvic pathology on imaging
- Refractory dyspareunia despite initial management
- Consideration of surgical intervention
Psychology or Sexual Medicine
- Significant psychological component identified
- History of sexual trauma affecting treatment
- Relationship distress requiring couples therapy
- Pain-fear-avoidance cycle requiring cognitive behavioral therapy
Troubleshooting Refractory Dyspareunia
Ask These Questions When Treatment Fails
- Is the diagnosis correct? — Reconsider differential; biopsy if not already done; additional imaging
- Are there multiple overlapping diagnoses? — Endometriosis plus vaginismus; atrophy plus vestibulodynia; treat all contributors
- Has pelvic floor dysfunction been addressed? — Secondary hypertonicity is almost universal; physiotherapy essential
- Was treatment duration adequate? — Vestibulodynia may take 6-12 months to improve; vaginal estrogen needs 8-12 weeks
- Was patient adherence good? — Topical treatments require consistent use; dilator therapy needs commitment
- Have psychological factors been addressed? — Anxiety, depression, trauma history, relationship issues all affect outcomes
- Has the partner been involved? — Partner education and support improves treatment success
- Is central sensitization present? — May require neuromodulators (amitriptyline, gabapentin) and pain psychology
8. Clinical Pearls and Pitfalls
Practical wisdom — learn from successes and avoid common mistakes
Must-Know Clinical Pearls
Location is everything: Superficial versus deep dyspareunia points to entirely different pathology. Always clarify this first — it directs the entire workup.
The Q-tip test is your best friend: A simple cotton swab can diagnose provoked vestibulodynia — the most common cause of superficial dyspareunia in premenopausal women.
Pelvic floor dysfunction is almost always present: Regardless of the primary cause, secondary pelvic floor hypertonicity develops in chronic dyspareunia. Always assess and treat the pelvic floor.
Vaginal estrogen works remarkably well: Genitourinary syndrome of menopause (vulvovaginal atrophy) is highly treatable. Most women see improvement within 4-8 weeks of vaginal estrogen.
Multiple diagnoses are the rule, not the exception: Expect to find more than one contributing factor in chronic dyspareunia. Address all of them for successful treatment.
Normal examination does not equal normal function: Vestibulodynia, endometriosis, and interstitial cystitis may all have unremarkable physical findings. Trust the history.
Ask about hormonal contraception: Combined oral contraceptives can cause vestibulodynia in susceptible women. A trial of discontinuation may be diagnostic and therapeutic.
The partner matters: Involve the partner in education and treatment planning. Partner support significantly improves outcomes; partner pressure worsens them.
Critical Pitfalls to Avoid
Dismissing the symptom as “psychological”: Dyspareunia always has a physical component. Labeling pain as “all in her head” delays diagnosis, damages trust, and causes harm. Even when psychological factors contribute, they interact with physical pathology.
Forcing the examination: Pushing through when a patient is in pain or frightened reinforces the pain-fear cycle and damages the therapeutic relationship. It is acceptable to defer internal examination and refer for pelvic floor physiotherapy first.
Assuming negative ultrasound excludes endometriosis: Peritoneal endometriosis and early-stage disease are not visible on ultrasound. A normal scan does not rule out endometriosis as a cause of deep dyspareunia.
Treating recurrent candidiasis without confirmation: Not all vulvar irritation is yeast. Chronic use of antifungals for unconfirmed candidiasis can cause irritant dermatitis and delay correct diagnosis. Culture before repeated treatment.
Forgetting to ask about medications: SSRIs, antihistamines, and hormonal contraceptives are common culprits. Always take a thorough medication history and consider drug-induced causes.
Neglecting the pelvic floor: Treating the primary pathology without addressing secondary pelvic floor dysfunction leads to treatment failure. Physiotherapy should be part of almost every treatment plan.
Expecting quick results: Chronic dyspareunia takes time to develop and time to resolve. Set realistic expectations — improvement may take months of multimodal therapy.
Not screening for intimate partner violence: Dyspareunia may be the presenting symptom of abuse. Always interview the patient privately and ask screening questions in a safe, non-judgmental manner.
Key Takeaways
- Dyspareunia affects 10-20% of women and is significantly underreported — always ask about sexual health
- Classify by location first: superficial (entry) dyspareunia suggests vulvovaginal causes; deep dyspareunia suggests pelvic pathology
- The “PAINFUL” mnemonic ensures systematic history: Position, Attributes, Inception, Nexus to cycle, Factors, Underlying history, Life impact
- Red flags requiring urgent evaluation include postcoital bleeding, pelvic mass, fever, and signs of domestic violence
- The Q-tip test is essential for diagnosing provoked vestibulodynia — the most common cause of superficial dyspareunia in premenopausal women
- Pelvic floor assessment should be performed on all patients; secondary hypertonicity is nearly universal in chronic dyspareunia
- Genitourinary syndrome of menopause (vulvovaginal atrophy) is highly prevalent postmenopausally and responds well to vaginal estrogen
- Endometriosis should be suspected in any woman with cyclical deep dyspareunia and dysmenorrhea, even with normal ultrasound
- Multiple diagnoses commonly coexist — always look for additional contributing factors
- Treatment requires a multimodal approach addressing physical pathology, pelvic floor dysfunction, and psychological factors
- Pelvic floor physiotherapy is a cornerstone of treatment for most causes of dyspareunia
- Set realistic expectations — chronic dyspareunia may take months of treatment to resolve
Quick Reference Algorithm
Systematic Approach to Dyspareunia:
- Screen for red flags — Exclude urgent conditions (bleeding, mass, fever, abuse)
- Localize the pain — Superficial (entry) versus deep; this determines the differential
- Take a detailed history — Use “PAINFUL” mnemonic; include medications, obstetric history, psychosocial factors
- Perform systematic examination — External inspection, Q-tip test, pelvic floor assessment, speculum, bimanual (defer if not tolerated)
- Investigate appropriately — Swabs for infection; transvaginal ultrasound for deep pain; biopsy visible lesions
- Identify all contributing factors — Expect multiple diagnoses; always assess for secondary pelvic floor dysfunction
- Initiate multimodal treatment — Address physical pathology, pelvic floor dysfunction, and psychological factors simultaneously
- Refer when needed — Pelvic floor physiotherapy for most; specialist referral for complex or refractory cases
- Follow up and reassess — Treatment takes time; adjust plan based on response; maintain therapeutic relationship